Introduction
Endometrial cancer (EC) is one of the most prevalent gynecologic malignancies in the United States. While historically characterized as a disease affecting older, post-menopausal women, recent clinical observations have suggested a shifting demographic landscape. Broad national statistics often mask critical nuances in how the disease burden is evolving across different age groups and racial/ethnic populations. This study aims to bridge the gap between general trends and demographic-specific realities by analyzing 20 years of high-quality registry data to identify "micro-trends" essential for targeted prevention and health equity.
Methodology
Researchers conducted a retrospective cohort study utilizing data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program.
- Incidence Analysis: Data was drawn from the SEER-17 registry (2000–2019), encompassing 217,228 confirmed cases and covering approximately 26% of the U.S. population.
- Mortality Analysis: The SEER-8 incidence-based mortality database was used to track 45,812 EC-related deaths over the same period.
- Statistical Modeling: The team employed Joinpoint Regression modeling to identify specific temporal points where trends significantly changed. Trends were quantified using Annual Percentage Change (APC) for short-term shifts and Average Annual Percent Change (AAPC) for the full 20-year summary.
Temporal Trends in Incidence and Mortality
The analysis revealed a significant overall increase in the burden of endometrial cancer. From 2000 to 2019, the overall age-standardized incidence rate was 32.76 per 100,000 person-years, with an annual increase of 0.95%. While overall mortality appeared stable when viewed across the full two decades, a closer look revealed a significant 0.29% annual increase from 2005 to 2019.
The "Younger Shift"
The most striking finding is the rapid rise of EC in younger cohorts. As shown in Figure 1B and 1D, incidence and mortality are surging in women aged 20–59. Specifically, the incidence among women aged 20–39 rose by 3.49% annually. Conversely, incidence in women aged 80+ actually decreased significantly (AAPC = -1.28%). This suggests that lifestyle factors or environmental exposures earlier in life are playing a larger role in disease development than previously understood.
Racial and Ethnic Disparities
Trends vary significantly by race and ethnicity. While non-Hispanic White women represent the majority of cases, their trends remained relatively stable compared to other groups. Hispanic women in the youngest cohort (ages 20–39) experienced the most dramatic increase in incidence, with an AAPC of 5.05%. Furthermore, non-Hispanic Black women face a disproportionate burden, characterized by higher incidence rates of aggressive, non-endometrioid subtypes (such as serous carcinoma) and faster-growing mortality rates compared to their White counterparts.
Discussion and Drivers of Change
The authors point to the "global epidemic" of obesity as a primary driver of these trends. Adipose tissue converts androgens to estrogens, leading to endometrial hyperplasia—a known precursor to cancer. The rising rates of childhood and adolescent obesity over the last four decades correlate strongly with the rising EC rates in young adults today.
Beyond lifestyle factors, the study highlights that racial disparities are reflected in the biology of the tumors themselves. Black women are more frequently diagnosed with aggressive subtypes that carry a poorer prognosis, highlighting a critical need to address both biological and socioeconomic factors in treatment and screening.
Conclusion
The incidence and mortality of endometrial cancer are rising rapidly among young and middle-aged U.S. women, marking a significant shift in the disease's epidemiology. These findings provide urgent evidence for the need to investigate specific risk factors driving these surges and to develop public health interventions that address the stark health disparities among different racial and ethnic groups.
Summary updated